Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Status
- COMPLETED
- Phase
- NA